Table 1.

Resting MAP recorded on separate days before drug treatments, as indicated.

Treatment	MAP (mmHg)
Group 1 (n = 4)
Saline	132 ± 14
Ang-(1-7) (15 pmol/kg/min)	124 ± 4
Candesartan (0.01 mg/kg)	131 ± 6
Ang-(1-7) and candesartan	134 ± 4
Group 2 (n = 7)
Saline	131 ± 13
Ang-(1-7) (15 pmol/kg/min)	136 ± 13
Candesartan (0.01 mg/kg)	126 ± 15
Ang-(1-7) and candesartan	136 ± 16
Group 3 (n = 6)
Ang-(1-7) (15 pmol/kg/min)	138 ± 8
Candesartan (0.1 mg/kg)	135 ± 8
Ang-(1-7) and candesartan	139 ± 11
Ang-(1-7), candesartan, and PD123319 (50 μg/kg/min)	139 ± 5
Group 4 (n = 7)
Ang-(1-7) (15 pmol/kg/min)	143 ± 10
Candesartan (0.1 mg/kg)	142 ± 10
Ang-(1-7) and candesartan	142 ± 9
Ang-(1-7), candesartan, and PD123319 (50 μg/kg/min)	137 ± 9
Group 5 (n = 8)
Ang-(1-7) (15 pmol/kg/min)	128 ± 11
Candesartan (0.1 mg/kg)	122 ± 10
Ang-(1-7) and candesartan	133 ± 5
Ang-(1-7), candesartan, and A779 (15 pmol/kg/min)	132 ± 2
Group 6 (n = 8)
Ang-(1-7) (15 pmol/kg/min)	129 ± 5
Candesartan (0.01 mg/kg)	126 ± 10
Ang-(1-7) and candesartan	132 ± 6
Ang-(1-7), candesartan, and A779 (15 pmol/kg/min)	125 ± 8

Values are ± SEM.